Dr Conor Hanley, co-founder and CEO of BiancaMed
BiancaMed, a medical technology start-up has secured €2.5 million in investment. Speaking about the investment, Dr Conor Hanley, CEO said, “BiancaMed is delighted to have secured this significant investment from such a prestigious global investor, with a proven track record in growing successful medical technology companies.” BiancaMed, whose target markets are the fast growing mobile and home-health sectors, was founded in 2003 and is based in NovaUCD, the Innovation and Technology Transfer Centre at UCD.
BiancaMed, a company that provides easy-to-use mobile phone and home based wellness and health monitoring technologies and services for use in daily life, was co-founded by Dr Philip de Chazal, Dr Conor Hanley and Professor Conor Heneghan as a spin-off from UCD’s School of Electrical, Electronic and Mechanical Engineering.
Increasingly stressful lifestyles, a rise in chronic diseases and obesity and an aging population are directly contributing to skyrocketing health care costs. BiancaMed is providing mobile phone and home based solutions that empower individuals and patients to better manage their wellbeing and health. In short, BiancaMed aims to transform wellbeing and health by providing the ultimate convenience in personal health monitoring.
At the core of BiancaMed’s product platform is a very sensitive motion sensor that detects heart rate and respiration completely wirelessly. The sensor, combined with the company's sophisticated health analysis software, provides solutions to monitor sleep, diet and exercise - the three elements of wellbeing.
Dr Pat Frain, Director, NovaUCD speaking about the investment said, “A major priority for UCD is the commercialisation of its research through a combination of licensing and the formation of spin-out companies. BiancaMed is an excellent example of a start-up company which was established to commercialise UCD intellectual property created by the founders of BiancaMed.” He added, “This investment demonstrates that university spin-outs, such as BiancaMed with strong intellectual property and cutting-edge technology continue to have the potential to attract significant investment to implement their business development plans.”
